AEON stock

AEON Biopharma, Inc. (AEON) financials · $8.6M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

AEON Biopharma, Inc. (AEON) $8.6M cap.

Cached annual income statement
LineFY2025FY2024
Operating Income-$12.8M$73.0M
Net Income-$39.2M$42.0M
EPS (Diluted)-$3.95$72.93
Cached annual balance sheet
LineFY2025FY2024
Total Assets$5.56M$3.14M
Current Assets$3.40M$1.59M
Cash & Equivalents$3.01M$13.0K
PP&E$162.0K$235.0K
Total Liabilities$60.6M$31.7M
Current Liabilities$6.90M$14.1M
Shareholders' Equity-$55.0M-$28.6M
Retained Earnings-$470.8M-$431.6M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$17.3M-$20.3M
CapEx$4.00KN/A
Investing Cash Flow-$4.00KN/A
Financing Cash Flow$20.3M$15.1M
Net Change in Cash$2.99M-$5.14M
Free Cash Flow-$17.3MN/A
These statements as JSON? API free 100/day

FAQ

What is AEON P/E and revenue?

AEON Biopharma, Inc. (AEON) $8.6M cap.

What is AEON revenue?

AEON income-statement cache has no revenue figure yet.

Is AEON profitable?

AEON Biopharma, Inc. last cached net income is -$39.2M (FY2025).

What are AEON total assets?

AEON Biopharma, Inc. last cached total assets are $5.56M (FY2025).

What is AEON free cash flow?

AEON Biopharma, Inc. last cached free cash flow is -$17.3M (FY2025).

Not investment advice. Cached statements, not a live tape.